Media Center

 

Third Rock News & Events

January 26, 2017 - Third Rock Ventures Names Sarah Larson as Partner
» Read More

October 31, 2016 - Third Rock Ventures Raises $616 Million Fund IV
» Read More

September 24, 2016 - Third Rock Ventures’ Venture Partner Phil Reilly to receive the Henri Termeer Lifetime Achievement Award at the 5th Annual Tribute to Champions of Hope
» Read More

May 23, 2016 - Third Rock Ventures’ Venture Partner Phil Reilly to Speak at MassBio Event to Discuss his New Book “Orphan: The Quest to Save Children with Rare Disease”
» Read More

April 25, 2016 - Third Rock Ventures' Partner, Robert Tepper, to Moderate Panel at the World Medical Innovation Forum
» Read More

April 6, 2016 - Third Rock Ventures' Partner, Cary Pfeffer, to Present at Xconomy's EXOME: What's Hot in Boston Biotech
» Read More

Portfolio News

Agios Pharmaceuticals
November 16, 2018 - Agios Presents Updated Data from Phase 1 Dose-Escalation Study of AG-881 in Patients with IDH Mutant Positive Advanced Glioma
» Press Release | Company News

Neon Therapeutics
November 16, 2018 - Neon Therapeutics Named a Top Place to Work in Massachusetts by The Boston Globe
» Press Release | Company News

bluebird bio
November 15, 2018 - bluebird bio to Present at the Evercore ISI HealthCONx Conference
» Press Release | Company News

Blueprint Medicines
November 15, 2018 - Blueprint Medicines Announces Updated NAVIGATOR Trial Results in Patients with Advanced Gastrointestinal Stromal Tumors Supporting Development of Avapritinib Across All Lines of Therapy
» Press Release | Company News

Constellation Pharmaceuticals
November 15, 2018 - Constellation Pharmaceuticals Highlights EZH2 Inhibition Program in Prostate Cancer at Biomedical Conference
» Press Release | Company News

Rhythm Pharmaceuticals
November 15, 2018 - Rhythm Pharmaceuticals Announces Presentation of Updated Clinical Data from Phase 2 Basket Studies Evaluating Setmelanotide in Alström Syndrome at ObesityWeek 2018
» Press Release | Company News

Ablexis
November 13, 2018 - Ablexis Announces Progress in Its Intellectual Property on AlivaMab Mouse and Immunoglobulin Locus Engineering
» Press Release | Company News

Jounce Therapeutics
November 13, 2018 - Jounce Therapeutics Reports Third Quarter 2018 Financial Results
» Press Release | Company News

REVOLUTION Medicines
November 13, 2018 - REVOLUTION Medicines Announces Presentations at Scientific Meetings in Third and Fourth Quarters of 2018
» Press Release | Company News

Myokardia
November 12, 2018 - MyoKardia Presents Preclinical Evidence of Mavacamten’s Novel Effect on Diastolic Compliance at the 2018 American Heart Association Scientific Sessions
» Press Release | Company News

News Archives